ENVOY MEDICAL, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+78.6% +$33K
$75K
Cost of Revenue↑+34.4% +$54K
$211K
R&D↑+84.3% +$2M
$5M
SG&A
—
D&A↑+66.7% +$32K
$80K
Operating Income↓-14.8% -$736K
$-6M
EBITDA↑+66.7% +$32K
$80K
Interest Expense↓-100.0% -$384K
$0
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
—
Net Income↓-8.8% -$522K
$-6M
Operating Margin↓-4711.9pts
-13590.5%
Net Margin↓-4790.5pts
-15433.3%
Effective Tax Rate
—
ETR (Continuing Operations)
—
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
0.2%
Operating Lease Cost↓-47.4% -$46K
$51K
Revenue YoY Variation↑+134.4pts
78.6%
Income YoY Variation↑+32.1pts
-14.8%
Revenue QoQ Variation↑+103.6pts
78.6%
Income QoQ Variation↓-10.1pts
-12.6%